InflaRx NVMEX:IFRXN 30 Market Cap is MXN4,829.81 Mil as of Jun. 26, 2026. GuruFocus rates MEX:IFRXN with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 1,431 Biotechnology companies, InflaRx NV ranks better than 62.89% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). InflaRx NV's share price for the quarter that ended in Mar. 2026 was MXN22. InflaRx NV's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 72.29 Mil. Therefore, InflaRx NV's market cap for the quarter that ended in Mar. 2026 was MXN1,590.45 Mil.
InflaRx NV's quarterly market cap
increased
from Sep. 2025 (MXN1,083.95 Mil) to Dec. 2025 (MXN1,590.45 Mil) but then
stayed the same
from Dec. 2025 (MXN1,590.45 Mil) to Mar. 2026 (MXN1,590.45 Mil).
InflaRx NV's annual market cap
declined
from Dec. 2023 (MXN2,247.56 Mil) to Dec. 2024 (MXN1,468.37 Mil) but then
increased
from Dec. 2024 (MXN1,468.37 Mil) to Dec. 2025 (MXN1,590.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. InflaRx NV's Enterprise Value for Today is MXN4,049.65 Mil.
InflaRx NV (MEX:IFRXN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
InflaRx NV Market Cap Related Terms
InflaRx NV Market Cap Historical Data
* Premium members only.
The historical data trend for InflaRx NV's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:IFRXN vs IRD, NAUT, RGNX: Market Cap Comparison
For the Biotechnology subindustry, InflaRx NV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InflaRx NV Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, InflaRx NV's Market Cap distribution charts can be found below:
* The bar in red indicates where InflaRx NV's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
InflaRx NV's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InflaRx NV (MEX:IFRXN) has a Market Cap of MXN4,829.81 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on InflaRx NV and its competitors. According to the industry distribution chart, InflaRx NV ranks #531 out of 1431 companies in the Biotechnology industry, placing it in the top 37.1%.
Is InflaRx NV's Market Cap too high?
InflaRx NV's current Market Cap is MXN4,829.81 Mil. Based on the distribution chart, InflaRx NV ranks #531 out of 1431 companies in the Biotechnology industry, which is above the industry midpoint. Overall, InflaRx NV has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Market Cap compare to IRD and NAUT?
According to the Biotechnology industry distribution chart, InflaRx NV ranks #531 out of 1431 companies for Market Cap. This puts InflaRx NV in the upper half of its industry. The industry median Market Cap is 113.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on InflaRx NV and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InflaRx NV's current Market Cap is MXN4,829.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (MEX:IFRXN) has a current Market Cap of MXN4,829.81 Mil. The current Market Cap is MXN4,829.81 Mil. InflaRx NV's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For InflaRx NV (MEX:IFRXN), the current Market Cap is MXN4,829.81 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
30GF Score
Get the complete analysis for MEX:IFRXN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:IFRXN has been successfully added to your 
